KT&G Launches ESSE Himalaya Winter with Advanced Flavor-reducing Technology

Innovation by 2FIRSTS.ai
May.28.2024
KT&G Launches ESSE Himalaya Winter with Advanced Flavor-reducing Technology
ENewsToday reported on May 27 that "ESSE Himalaya Winter" features tobacco from the Himalayas and Cold Locking Tech.

According to ENewsToday on May 27th, the new series "ESSE Himalaya Winter" stands out for its use of tobacco leaves from the Himalayas and Cold Locking Tech. In addition, the product enhances the reduction of tobacco smell in the mouth after smoking by utilizing advanced flavor-reducing technology.

 

KT&G Launches ESSE Himalaya Winter with Advanced Flavor-reducing Technology

 

The packaging design of this product incorporates a navy blue color with black and features an image of the Himalayan mountain range to emphasize the scent and image of "ESSE Himalaya Winter". The tar and nicotine content of "ESSE Himalaya Winter" are 1.0mg and 0.10mg respectively, and it is priced at 4500 Korean won (approximately $3.30) per pack.

 

"ESSE Himalaya Winter" is the first extension product of KT&G's "ESSE Himalaya" series to apply flavor reduction technology. Since its initial launch in South Korea in 2019, the series has rapidly gained popularity, with sales of approximately 10 million packs within four months of its release. This has paved the way for a new trend in reducing the smell of tobacco.

 

Song Seung-Cheol, head of the ESSE team at KT&G, stated, "ESSE Himalaya Winter not only enhances the natural aroma of tobacco leaves from clean regions such as the Himalayas, but also improves the effectiveness of reducing tobacco odor through KT&G's unique technology.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts
France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts
2Firsts has learned that France’s national health authority, the Haute Autorité de Santé (HAS), confirmed the role of e-cigarettes will be addressed in updated national smoking-cessation guidelines expected by the end of 2026. HAS said the recommendations will focus on clinical and public-health considerations, will not set technical standards for vaping products, and that current studies are insufficient to clearly assess risks and benefits across different product categories.
Mar.10
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
Philip Morris International (PMI), through its subsidiary Swedish Match, has started large-scale production at a 600,000-square-foot ZYN nicotine pouch facility in Aurora, Colorado. The $600 million investment makes the site one of three ZYN manufacturing plants in the United States and the company’s second U.S. facility after Owensboro, Kentucky.
PMI
Feb.21
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
Illinois HB 4652 Targets Discarded Vapes, Would Require Manufacturer-Funded Disposal Programs
Illinois HB 4652 Targets Discarded Vapes, Would Require Manufacturer-Funded Disposal Programs
Illinois House Bill 4652 proposes e-cigarette companies establish and fund safe disposal programs to combat environmental risks.
Mar.09 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.
Feb.06 by 2FIRSTS.ai